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Summary
The factors influencing the tissue-specific pattern of so-
matic mosaicism in CAG-repeat diseases have not yet
been fully resolved. We performed a detailed analysis of
the degree of somatic mosaicism in various tissues from
20 patients with spinal and bulbar muscular atrophy
(SBMA), including 4 who were deceased. The most out-
standing feature was the prominent somatic mosaicism
observed in the cardiac and skeletal muscles, composed
predominantly of postmitotic cells, and in the skin, pros-
tate, and testis. The CNS tissues, liver, and spleen
showed the least mosaicism. The tissue distribution of
somatic mosaicism in patients with SBMAwasmarkedly
different from that in patients with Huntington disease
(HD) and from that in patients with dentatorubral-pal-
lidoluysian atrophy (DRPLA). The degree of somatic
mosaicism correlated with the CAG-repeat number but
not with age at examination. Furthermore, tissues with
a higher mosaicism level corresponded well to thosewith
a higher expression level of androgen receptor protein.
The tissue-specific pattern of somatic mosaicism related
not only to cell composition with different cell turnover
rates but to repeat size and gene expression levels, and
postnatal cell division is unlikely to be a major cause of
somatic mosaicism probably because of the relative sta-
bility of CAG repeat in SBMA.
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Introduction
Spinal and bulbar muscular atrophy (SBMA [MIM
313200]) is an X-linked, recessive, inherited neurode-
generative disorder characterized by motor-neuron loss
in the spinal cord and brain stem and is associated with
a less extensive loss of sensory neurons and chronic de-
nervation atrophy in the skeletal muscles (Kennedy et
al. 1968; Sobue et al. 1989).
SBMAwas first proved to be caused by unstable CAG-
repeat expansions of the androgen receptor (AR) gene
(La Spada et al. 1991). The number of CAG-repeat units
of normal alleles in the AR gene is 14–32, whereas that
of expanded alleles is 40–55 (Tanaka et al. 1996a). Re-
cently, affected tissue-specific intranuclear inclusions of
the mutant protein have been detected in CAG-repeat
diseases, including SBMA (Li et al. 1998a). However,
the latest reports indicate that nuclear aggregation of
ataxin-1 and huntingtin are not required for initiation
of pathogenesis of spinocerebellar ataxia type 1 (SCA1)
in transgenic mice (Klement et al. 1998) or cultured neu-
rons of Huntington disease (HD) (Saudou et al. 1998).
Therefore, at present, the pathogenic role of intranuclear
inclusions of mutant proteinmediated by polyglutamine-
directed aggregation remains unknown.
The triplet-repeat instability in somatic cells within an
individual is known as “somatic mosaicism.” The first
evidence of heterogenic somatic mosaicism of the CAG
repeat in various tissues was provided by Telenius et al.
(1994). In subsequent reports on SCA1 (Chong et al.
1995; Lopes-Cendes et al. 1996; Hashida et al. 1997),
dentatorubral-pallidoluysian atrophy (DRPLA) (Ueno et
al. 1995; Takano et al. 1996; Tanaka et al. 1996b;Hash-
ida et al. 1997), and Machado-Joseph disease (MJD)
(Lopes-Cendes et al. 1996; Tanaka et al. 1996b; Hashida
et al. 1997), several features of somatic mosaicism were
described despite their distinct neuropathology. Unlike
the mutant allele in other regions, a shortening, by sev-
eral repeat units, of the mutant allele in the cerebellar
cortex is common to these CAG-repeat diseases (Telenius
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Figure 1 Somatic mosaicism of the CAG repeats in SBMA tissues
(patients 2 and 4). The main peak of the expanded CAG allele showed
invariably the same size—46 (patient 2) and 50 (patient 4)—among
all examined tissues, including those of the cerebellum. The expanded
alleles showed a considerable variation in CAG-repeat ranges of dif-
ferent tissues, indicating the presence of tissue-specific somatic mo-
saicism. The widest variation in the CAG-repeat range was observed
in the cardiac muscle, skeletal muscles, skin, prostate, and testis. Over-
all, the CNS tissues displayed a narrower range of expanded alleles
than did the tissues described above. Of the visceral organs, the liver
and the spleen showed the least mosaicism.
et al. 1994; Chong et al. 1995; Ueno et al. 1995; Lopes-
Cendes et al. 1996; Takano et al. 1996; Tanaka et al.
1996b; Hashida et al. 1997). Such a common pattern
of somatic mosaicism, irrespective of different CAG-re-
peat diseases, has drawn attention to the cellular mitotic
potential as one possible factor influencing the degree
of somatic mosaicism. Tissues that constantly undergo
cell division would display a greater heterogeneity and
larger expansion, whereas mitotically quiescent tissues,
such as the cerebellar cortex, skeletal, and cardiac mus-
cle, would show less heterogeneity and smaller expan-
sion (Chong et al. 1995; Takano et al. 1996; Hashida
et al. 1997).
Several problems involving the somatic mosaicism of
CAG repeats, however, have not been resolved. First,
why is it that tissues with a higher cell-turnover rate,
such as blood, liver, and colon, do not necessarily show
a higher degree of mosaicism? Second, if the tissue-spe-
cific postnatal cell-turnover rate is the major factor gov-
erning tissue-specific mosaicism, why is there no com-
mon pattern of somatic mosaicism present among the
triplet-repeat diseases? Third, how is the degree of so-
matic mosaicism related to the degree of CAG-repeat
size or expression level of the responsible gene?
In this study, we performed a detailed analysis of the
degree of somatic mosaicism in various tissues from 20
patients with SBMA, including 4 who were deceased.
The most outstanding finding was that the most prom-
inent somatic mosaicism was observed in the cardiac and
skeletal muscles, composed predominantly of postmi-
totic cells, as well as in the skin, prostate, and testis.
These tissues corresponded well to those with a higher
expression level of the AR gene, which may provide new
insights into the molecular basis of somatic mosaicism
of CAG-repeat diseases.
Patients, Material, and Methods
Patients and Samples
Tissue samples from 20 subjects with SBMA, age
42–74 years (mean  SD = ), were studied.55.1 8.7
The four deceased patients had the typical clinical pro-
gression of SBMA, with onset of proximal-limb weak-
ness followed by proximal-limb wasting, tongue atro-
phy, generally depressed tendon reflexes, mild loss of
vibration sense, and gynecomastia. These four patients
died of respiratory failure at the ages of 64 years (patient
1), 74 years (patient 2), 52 years (patient 3), and 59
years (patient 4).
We investigated the degree of somatic mosaicism in
18 different neural and nonneural tissues of patient 1,
41 of patient 2, 20 of patient 3, 23 of patient 4, and 12
of the control subject. To assess the possible correlation
of the somatic mosaicism level with age and CAG-repeat
number, we further examined 17 muscle and 10 skin
samples obtained at biopsy or autopsy of our 20 patients
with SBMA. Those tissue samples were snap-frozen in
liquid nitrogen and were stored at 80C. A part of
each tissue sample was fixed in 10% formalin solution
and was processed for histopathological assessment, as
described elsewhere (Sobue et al. 1989; Li et al. 1995).
For comparison with our findings on patients with
SBMA, we analyzed the somatic mosaicism of four pa-
tients with HD, one of whom was deceased (patient
1—54 years, CAG 47; patient 2—40 years, CAG 48;
patient 3—51 years, CAG 37; and patient 4—60 years,
CAG 42), and of one deceased patient who had had
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Figure 2 Range of expanded alleles, histopathological findings, and immunohistochemical reactivity for AR in four deceased patients with
SBMA. The range of expanded CAG-repeat sizes in each tissue is indicated where the main peak size is designated as “0.” There is no apparent
relationship between the range of expanded alleles and the histopathology, although tissue-specific AR-gene expression level correlated well
with tissue-specific pattern of somatic mosaicism of CAG repeats in SBMA.Histopathological findings were graded as follows: = nopathological
changes;  = detectable and mild pathology;  = moderate involvement;  = severe and advanced pathological changes. The grading
system in our previous report (Sobue et al. 1989) serves as a basis for the grading system in this report. Immunohistochemical reactivity for
AR was graded as described in the Patients, Material, and Methods section.
DRPLA (45 years, CAG 69). Informed consent was ob-
tained from all living patients for biopsy and DNA anal-
ysis, and from the family members of deceased patients
and deceased control subject for DNA analysis.
Analysis of CAG Repeat
By means of careful dissection, 50–100 mg of frozen
tissue was obtained from each region. The homogenized
tissues were incubated with lysis solution containing
Proteinase K at a final concentration of 100 mg/ml at
55C for 16 h, and the DNA was gently extracted three
times with phenol/chloroform. A sufficient removal of
contaminating proteins was confirmed by an A260/280
ratio of 11.8 of the isolated DNA samples.
PCR amplification of the CAG repeat in the AR gene
was performed with reaction volumes of 10 ml contain-
ing 150 ng of purified genomic DNA, 0.4 mM of each
fluorescein-labeled primer (5′-TCCAGAATCTGTTCC
AGAGCGTGC-3′) and (5′-CCTGTGGGGCCTCTACG
ATGGGCTTG-3′), 1 # PCR buffer (50 mM KCl, 10
mM Tris-HCl [pH 8.3]), 1.5 mM MgCl2, 200 mM each
of dATP, dCTP, dGTP, and dTTP, and 0.1 U of Taq
polymerase (Takara). PCR conditions were 35 cycles of
denaturation at 95C for 60 s, annealing at 65C for 90
s, and elongation at 72C for 120 s, with a final exten-
sion of 7 min. Two microliters of PCR products were
combined with 4 ml of 95% formamide loading dye and
then were heated to 95C for 5 min before separation
by electrophoresis in 6% HydroLink LongRanger gels
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Figure 3 Somatic mosaicism of the CAG repeat in tissue samples from patients with either DRPLA or HD. Tissue-specific somatic
mosaicism was more pronounced in the CNS tissues, except for the cerebellar cortex, than in the peripheral blood, cardiac muscle, and skeletal
muscles and was markedly different from that of patients with SBMA.
(AT Biochem) by an autoread sequencer (ALFred; Phar-
macia). Their sizes were determined by comparison with
M13 DNA dideoxy sequencing ladders. The range of
expanded alleles was defined as the number of peaks
giving 15% of the height of the main peak (the highest
peak) (fig. 1).
The correlation of the somatic mosaicism level with
age and CAG-repeat number was statistically analyzed
by the Pearson-correlation-coefficient procedure. For
this purpose, only the number of peaks with a repeat
size larger than that of the main peak was used as the
index of the mosaicism level (degree of mosaicism). PCR
conditions for the CAG repeats of HD andDRPLA genes
are as described elsewhere (The Huntington’s Disease
Collaborative Research Group 1993; Nagafuchi et al.
1994b), and the methods of electrophoresis and analysis
are the same as described above.
Immunohistochemistry of Tissue Samples
Cryostat 8-mm sections were prepared from snap-fro-
zen tissue samples of the deceased patients with SBMA.
For tissue and cellular localization analysis of the AR
protein, we used PG-21 (rabbit polyclonal antibody
[IgG]; Affinity BioReagents) and AR(N-20) (rabbit poly-
clonal antibody [IgG]; Santa Cruz Biotechnology),which
recognize 21- and 20-amino-acid residues of the N-ter-
minus of the AR as the primary antibody. Details of the
procedure are as described elsewhere (Li et al. 1998a,
1998b).
Immunoblot Analysis
Two hundred milligrams of each tissue sample (frontal
cortex, thoracic cord, liver, spleen, kidney, cardiac mus-
cle, tongue, iliopsoas, prostate, skin, and testis) collected
from a deceased patient who had had SBMA (patient 4)
was homogenized in 50mMTris-HCl (pH 7.4), 1% (vol/
vol) Nonidet P-40, 0.1% (vol/vol) sodium deoxycholate,
0.1% SDS, 0.15 M NaCl, 1 mM EDTA, and 10 mg
aprotinin/ml. Homogenates were spun at 15,000 g, and
the supernatants were used for analysis of protein
expression. Protein concentration was determined by
means of the Bradford test (Bio-Rad Protein Assay; Bio-
Rad Laboratories). Fifty micrograms of protein extracts
were separated on a 10% SDS-PAGE (Mini-PROTEAN
II Ready Gels; Bio-Rad Laboratories), and immunoblots
were prepared and probed with PG-21 (1:250 dilution)
by means of procedures described elsewhere (Li et al.
1998a). After the detection of immunoreactivity, the sig-
nal intensity for each tissue was evaluated by National
Institutes of Health (NIH) image version 1.61 software
(W. Rasband, NIH).
Results
Tissue-Specific Pattern of Somatic Mosaicism in SBMA
Pathology examination of all four deceased patients
showed typical features of SBMA (Kennedy et al. 1968;
Sobue et al. 1989; Li et al. 1995), with severe neuronal
loss and mild gliosis in the spinal anterior horn and
brain-stem motor-neuron nuclei. The dorsal root–
ganglion neurons were also mildly affected by the pres-
ence of residual nodules. The skeletal muscle showed
marked chronic denervation atrophy with extensive fi-
ber-type grouping. The CNS tissues other than lower
motor neurons were well preserved. The details of his-
topathological involvement in each tissue are described
in figure 2.
The normal CAG allele from a control subject showed
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Figure 4 Correlation of the degree of somatic mosaicism with
age and CAG-repeat number, in muscle and skin samples from patients
with SBMA. The degree of somatic mosaicism in muscles correlated
significantly with CAG-repeat number ( , , ) (A)n = 17 r = .764 P ! .001
but not with age at examination (B). In the skin, it correlated with
CAG-repeat number ( , , ) (C) but not with agen = 10 r = .715 P ! .05
at examination (D).
Figure 5 Western blot analysis of tissues from a patient (patient
4) with SBMA. Each lane contained 50 mg of protein extracts. PG-
21 detected a 109-kD AR protein for examined tissues with variable
expression levels. Each bar represents the signal intensity of AR im-
munoreactivity, expressed as a percentage of testis. Strong signal in-
tensity was observed in the cardiac muscle, tongue, iliopsoas, prostate,
skin, and testis, as compared with the CNS, liver, and spleen.
a discrete major peak, invariably with the same size of
22 among all tissues examined, without detectable het-
erogeneity except for 1- or 2-repeat-smaller peaks of
PCR artifacts (Litt et al. 1989) during the amplification
of microsatellite repeats (data not shown).
The size of the main peak of the expanded alleles in
SBMA was identical among all examined tissues includ-
ing the cerebellum in each patient (patient 1, CAG 45;
patient 2, CAG 46 (fig. 1); patient 3, CAG 47; and pa-
tient 4, CAG 50 (fig. 1). However, the expanded alleles
showed a considerable variation in the CAG-repeat
ranges of different tissues. The tissue-specific PCR pat-
terns were highly reproducible within the patient even
when different regions of the same tissue were analyzed
or the primer set was changed (data not shown). Fur-
thermore, the patterns were also reproducible between
examined patients (figs. 1 and 2). Taken together, the
repeat changes seen in the various tissues indicate the
presence of tissue-specific somatic mosaicism (figs. 1 and
2). The ranges of expanded alleles in all tissues of these
four patients with SBMA are schematically illustrated in
figure 2.
The widest variation in the CAG-repeat range was
observed in the cardiac muscle, skeletal muscles, skin,
prostate, and testis (figs. 1 and 2). Although we exam-
ined a number of the skeletal muscles in the proximal
and distal extremities as well as in the tongue and di-
aphragm, the expanded alleles ranged to a similar extent
in all muscles independently of the pathological severity
in one individual (figs. 1 and 2). Overall, CNS tissues
displayed a narrower range of expanded alleles than the
aforementioned visceral tissues with a wider range of
CAG repeats (figs. 1 and 2). Among visceral organs, the
adrenal, liver, and spleen showed the least mosaicism
(figs. 1 and 2).
Comparison of Mosaicism Pattern between Patients
with SBMA and Patients with either HD or DRPLA
To confirm whether such a tissue-specific pattern of
mosaicism is specific to SBMA, we further analyzed tis-
sue samples from one deceased individual who had had
HD and from one deceased individual who had had
DRPLA, as well as biopsied skin samples from three
patients with HD, since the somatic mosaicism of non-
neural tissues, such as cardiac muscle, skeletal muscles,
skin, prostate, and testis, has not been well investigated
in individuals with either HD or DRPLA. The expanded
alleles differed extensively among tissues, and tissue-spe-
cific somatic mosaicism was more pronounced in the
CNS tissue, except for the cerebellar cortex, than in pe-
ripheral blood, cardiac muscle, and skeletal muscles (fig.
3). In patients with HD, the pronounced CAG-repeat
mosaicism was observed in the CNS—rather than in
peripheral blood and cardiac muscle, as it is in patients
with DRPLA. The liver showed a somewhat higher de-
gree of heterogeneity than did the blood (fig. 3). As
shown in figure 3, in patients with HD the degree of
somatic mosaicism in skin did not differ from that in
blood. Our observations of patients with either HD or
Tanaka et al.: Mosaicism and AR Expression in SBMA 971
DRPLA were markedly different from our observations
of patients with SBMA, who had a higher degree of
mosaicism in cardiac muscle, skeletal muscles, skin,
prostate, and testis and a lower degree of mosaicism in
CNS, liver, spleen, and peripheral blood.
Correlation of Somatic Mosaicism Level with Age and
CAG-Repeat Number in Patients with SBMA
We further analyzed the correlation of the degree of
somatic mosaicism to age and CAG-repeat number, in
17 muscle and 10 skin samples obtained at biopsy or
autopsy from the 20 patients with SBMA. SBMAmuscle
and skin consistently revealed a higher degree of mo-
saicism than did peripheral blood. The degree of somatic
mosaicism in muscles significantly correlated with the
CAG-repeat number ( , , ; fig. 4A)n = 17 r = .764 P ! .001
but not with age at examination ( , ,n = 17 r = .344 P =
; fig. 4B). In the skin, it also correlated with the.178
CAG-repeat number ( , , ; fig. 4C)n = 10 r = .715 P ! .05
but not with age at examination ( , ,n = 10 r = .134 P =
; fig. 4D)..712
Correlation of Somatic Mosaicism Level in SBMA to
AR Gene Expression
In immunohistochemistry, the skeletal muscles, pros-
tate, skin (including scrotal skin), and testis showed the
strongest immunoreactivity for AR (fig. 2). The cardiac
muscle also showed a considerably strong immunoreac-
tivity. In CNS tissues, the immunoreactivity was also
observed on neurons, but overall immunoreactive inten-
sity in the tissue was lower than that in the aforemen-
tioned tissues (fig. 2). The liver and spleen were not
immunoreactive for AR, or they were positive, if at all,
at a very low level (fig. 2).
The result of immunoblot analysis, shown in figure 5,
was generally compatible with that of immunohisto-
chemistry. Strong signal intensity was observed in the
cardiac muscle, tongue, iliopsoas, prostate, skin, and tes-
tis, as compared with the CNS, liver, and spleen (fig. 5).
Such tissue-specific AR-gene expression levels assessed
by immunohistochemistry and immunoblot analysis cor-
related well with the tissue-specific pattern of somatic
mosaicism of CAG repeats in SBMA (fig. 2), whereas
the distribution and severity of tissue-specific pathology
did not correlate with the level of somatic mosaicism
(fig. 2).
Discussion
The observed tissue-specific size heterogeneity in trip-
let-repeat diseases has so far been explained by the post-
natal cell-turnover rates of each tissue (Chong et al.
1995; Ueno et al. 1995; Lopes-Cendes et al. 1996; Tak-
ano et al. 1996; Hashida et al. 1997). The importance
of postnatal instability is also confirmed by the obser-
vation that the degree of size heterogeneity increases
with age in human DRPLA tissues (Takano et al. 1996)
and in transgenic-mice HD tissues (Mangiarini et al.
1997).
The striking observation in this study was the rela-
tively increased instability observed in cardiac muscle,
skeletal muscle, skin, prostate, and testis in patients with
SBMA. In other CAG-repeat diseases, such as HD and
DRPLA, skeletal muscle and cardiac muscle have been
shown to display the least mosaicism (Takano et al.
1996; Tanaka et al. 1996b; Mangiarini et al. 1997), as
confirmed by our results (fig. 3). Furthermore, in HD,
the prostate reveals the lowest degree of mosaicism,
whereas the testis is at an intermediate level, similar to
that of the blood (Telenius et al. 1994). As for the skin,
our assessment of three patients with HD has shown no
significant differences, in the degree of mosaicism, be-
tween the skin and the blood, in contrast with patients
with SBMA (fig. 3). Taken together, increased instability
in the cardiac muscle, skeletal muscle, skin, prostate, and
testis in patients with SBMA is a unique feature of tissue-
specific somatic mosaicism, as compared with patients
with either HD or DRPLA. Furthermore, in contrast
with the higher degree of mosaicism reported in CNS
tissues in patients with either DRPLA (Takano et al.
1996) or HD (Telenius et al. 1994) (fig. 3), a relatively
low degree of mosaicism was observed in CNS tissues
in patients with SBMA (figs. 1 and 2). The exaggerated
pattern of somatic mosaicism in SBMA muscle and skin
as compared with blood was further confirmed by the
biopsy specimens (fig. 4).
Although muscle cells are postmitotic, secondary cell
division could occur in the proliferation of satellite cells
with regeneration (Campion 1984) and could explain
the increased instability in SBMA muscle. However,
muscle-cell regeneration is rare in SBMA (data not
shown), and cannot account for the relatively marked
degree of mosaicism in muscle. Furthermore, if second-
ary pathological cell division has an important role, the
degree of somatic mosaicism might differ, depending on
the pathological severity, particularly among the prox-
imal-limb muscles (more profoundly affected in patients
with SBMA) and the distal-limb muscles (less affected).
However, a similar degree of somatic mosaicism was
observed in all muscles (figs. 1 and 2). In addition, lack
of correlation between age and degree of mosaicism in
muscles (fig. 4B) indicates that postnatal cell division is
unlikely to be a significant factor in the increased insta-
bility in muscle. In patients with SBMA, the cardiacmus-
cle consisting of postmitotic cells showed a higher degree
of mosaicism, and the skin, one of the tissues with the
highest cell-turnover rate, did not show an increased
somatic mosaicism with age (fig. 4D). Thus, postnatal
cell division is unlikely to be a major cause of somatic
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mosaicism, but it is strongly suggested that the degree
of somatic mosaicism is mainly determined at the stage
of embryogenesis and changes little postnatally in
SBMA. This may be explained by the relative stability
of the CAG-repeat tract in SBMA, among CAG-repeat
diseases (Tanaka et al. 1996a, 1996b).
Another interesting observation on skeletal muscle
and skin was that the degree of somatic mosaicism cor-
related not with age but with CAG-repeat size (fig. 4A
and C). The correlations between the extent of repeat-
size heterogeneity and age or CAG-repeat number vary
among triplet-repeat diseases (Telenius et al. 1994; Tak-
ano et al. 1996; Maciel et al. 1997). In DRPLA, the
degree of somatic mosaicism in the cerebral cortex, ce-
rebral white matter, and cerebellar white matter corre-
lates with age and not with the CAG-repeat number
(Takano et al. 1996), whereas in MJD and SCA1, the
degree of mosaicism is not correlated with age or CAG-
repeat number (Maciel et al. 1997). In patients withHD,
there is a trend toward increasing mosaicism with larger
repeat size (Telenius et al. 1994). The most striking ob-
servation in this study was the higher degree of somatic
mosaicism found in tissues with a higher expression level
of the AR gene (figs. 2 and 5). In patients with SBMA,
the AR gene is widely expressed throughout neural and
nonneural tissues, but its expression levels are very dif-
ferent among different tissues (figs. 2 and 5). The AR
protein level assessed by western blots and immunoh-
istochemistry in this study was high in the cardiac mus-
cle, skeletal muscle, skin, prostate, and testis, but low
in the liver and spleen (figs. 2 and 5). AR staining of the
CNS tissues was present (fig. 2), but the amount of AR
immunoreactivity in whole tissues was much lower than
that in the prostate, testis, skin, and muscle (fig. 5), and
mosaicism levels were lower in CNS (fig. 2).
In patients with either DRPLA or HD, gene products
atrophin-1 and huntingtin are widely expressed in var-
ious tissues, but the expression level in CNS tissues is
significantly higher than that in non-CNS tissues (Strong
et al. 1993; Nagafuchi et al. 1994a), and the somatic
mosaicism in CNS tissues is more pronounced than that
in non-CNS tissues (fig. 3) (Telenius et al. 1994; Takano
et al. 1996). In HD- and SBMA-model mice, an absence
of somatic instability was noted in transgenic lines that
failed to express the mutant transgene (Mangiarini et al.
1997; La Spada et al. 1998), implying that expression
of the responsible gene is correlated with somatic insta-
bility of the expanded repeats.
These findings in SBMA and other CAG-repeat dis-
eases and transgenic mice raise the possibility that gene
expression plays an important role in modulation of the
gene-specific and tissue-specific patterns in somatic mo-
saicism. The underlying molecular mechanism of the
correlation between gene expression and somatic insta-
bility is unknown. In summary, the tissue-specific pattern
of somatic mosaicism is related to repeat size and gene
expression level, and postnatal cell division is unlikely
to be a major cause of somatic mosaicism in individuals
with SBMA.
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